Moxifloxacin Tablet, Film Coated
Product Images NDC 73473-903

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Moxifloxacin (NDC 73473-903). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solaris Pharma Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Label for Moxifloxacin Tablets USP 400 mg film-coated tablets. The label includes the NDC 73473-903-30, distributed by Solaris Pharma Corporation and manufactured by Sunshine Lake Pharma Co., Ltd. It specifies a package size of 30 tablets and indicates storage instructions and pharmacist dispensing guidance.*

FDA Label Image

Logo (Logo1)

FDA Label Image

Logo (Logo3)

FDA Label Image

Plasma Figure (Plasmacurve)

A pharmacokinetic line graph comparing plasma concentration (µg/mL) over time (hours) following oral and intravenous (i.v.) doses of a drug. The graph shows plasma concentration decreasing over 24 hours for both administration routes, with data points connected by lines indicating oral dose and i.v. dose.*

FDA Label Image

Chemical Structure (Structure)

Chemical structure diagram of moxifloxacin hydrochloride showing its molecular framework with various functional groups including fluorine, methoxy, and cyclopropyl moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.